It is well established that the physiological changes in pregnancy can affect the course of rheumatoid arthritis (RA). Thus pregnancy is associated with remission of the disease in the last trimester, which frequently relapses after delivery.' This may be explained by the large rise in female sex hormone concentration and the subsequent fall postnatally. The disease suppression has also been related to the concentration of pregnancy serum a2 glycoprotein (PAG),2 though PAG levels in their turn are related to female sex hormones. 3 The possibility that such hormones affect RA disease activity is supported by the observation that the latter fluctuates during different stages of the menstrual cycle.4 These and other studies5 have prompted increased interest as to whether female sex hormones also have a role in the causation of RA. The most prominent hypothesis is that exogenous female sex hormones, specifically the oral contraceptive pill, protect against the development of RA. Four further studies, all using a case-control design, have been published recently, one supporting a protective effect,'0 two finding no benefit" 12 (the second being an extended and more rigorous version of the first), and one with equivocal results,'3 perhaps due to small numbers. The methodological aspects of these studies have been discussed in detail in an attempt to explain the divergent results,1416 and lengthy epidemiological discussion has failed to reconcile the differences. The US National Institute of Health in 1984 was sufficiently impressed by the potential importance of the question that it expressed a willingness to sponsor 'the definitive' case-control study. 17 (Fig. 1) . Such a hierarchy is reasonably associated with increased exposure to pregnancy, though in part could be explained by age differences between the marital groups. The same survey showed that the age adjusted prevalence of RA was lowest in nulliparous women and highest in those with more than four children28 (Fig. 2) . Other studies, however, have found no effect of marital status. 23 29 30 A study by Kay and Bach also showed a lower fertility rate in women with RA than in age matched controls.30 This observation was partly ascribed to the effect of the disease, but reduced fertility was seen even in the subgroup with postmenopausal disease onset. There were differences, however, between seropositive and seronegative women (as classified by the serological techniques available at that time), the former having a higher fertility before disease onset. This group also had a higher rate of spontaneous abortions than either seronegative or control women. Thus pregnancy experience may be a risk factor in the aetiology of seropositive disease, with failed pregnancy a more potent risk factor. The latter would be consistent with the study on autoimmune thyroid disease mentioned above.
Epidemiological data collected for other purposes can be examined for their consistency in regard to the pregnancy hypothesis. There are differences in the association of HLA, and in particular the class II antigen DR4, and RA between men and women. A study of 440 RA patients showed that with increasing age of RA onset there was a linearly decreasing 
